
==== Front
Clin Cancer Res
Clin Cancer Res
Clinical Cancer Research
1078-0432
1557-3265
American Association for Cancer Research

CCR-24-2112
10.1158/1078-0432.CCR-24-2112
Version of Record
Corrections
Correction: BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Kurata Keiji
Samur Mehmet K.
Liow Priscilla
Wen Kenneth
Yamamoto Leona
Liu Jiye
Morelli Eugenio
Gulla Annamaria
Tai Yu-Tzu
Qi Jun
Hideshima Teru
Anderson Kenneth C.
Clin Cancer Res 2024;30:3956

03 9 2024
03 9 2024
03 9 2024
30 17 39563956
03 7 2024
10 7 2024
©2024 The Authors; Published by the American Association for Cancer Research
2024
American Association for Cancer Research
https://creativecommons.org/licenses/by/4.0/ This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
==== Body
pmcIn the original version of this article (1), an incorrect FACS plot was used to represent CD138− patient myeloma cells in Supplementary Fig. S1G. Supplementary Fig. S1 has been replaced with a corrected version in the latest online HTML version of the article. The authors regret this error.
==== Refs
Reference

1. Kurata K , SamurMK, LiowP, WenK, YamamotoL, LiuJ, . BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clin Cancer Res 2023;29 :1807–21.36780189
